Patterson Companies (NASDAQ:PDCO) Now Covered by StockNews.com

StockNews.com started coverage on shares of Patterson Companies (NASDAQ:PDCO) in a research note published on Wednesday. The brokerage issued a hold rating on the stock.

Patterson Companies Stock Performance

Shares of NASDAQ:PDCO opened at $31.33 on Wednesday. The company’s 50 day simple moving average is $31.23 and its 200 day simple moving average is $28.92. The stock has a market capitalization of $2.77 billion, a price-to-earnings ratio of 18.32, a price-to-earnings-growth ratio of 2.71 and a beta of 0.73. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.37 and a quick ratio of 0.76. Patterson Companies has a 1 year low of $19.45 and a 1 year high of $31.79.

Institutional Trading of Patterson Companies

A number of hedge funds and other institutional investors have recently modified their holdings of PDCO. Barclays PLC grew its stake in shares of Patterson Companies by 37.2% during the third quarter. Barclays PLC now owns 165,715 shares of the company’s stock worth $3,619,000 after buying an additional 44,906 shares during the last quarter. Profit Investment Management LLC grew its stake in shares of Patterson Companies by 7.8% during the fourth quarter. Profit Investment Management LLC now owns 101,685 shares of the company’s stock worth $3,138,000 after buying an additional 7,338 shares during the last quarter. Dakota Wealth Management bought a new stake in shares of Patterson Companies during the fourth quarter worth $1,032,000. Janney Montgomery Scott LLC bought a new stake in shares of Patterson Companies during the fourth quarter worth $1,121,000. Finally, Exchange Traded Concepts LLC grew its stake in shares of Patterson Companies by 2.6% during the fourth quarter. Exchange Traded Concepts LLC now owns 36,159 shares of the company’s stock worth $1,116,000 after buying an additional 915 shares during the last quarter. Institutional investors own 85.43% of the company’s stock.

Patterson Companies Company Profile

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.